Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being…
Conditions studied
Breast Carcinoma, Lung Carcinoma
About this study
This clinical trial assesses the use of advocates and supporters of breast and lung cancer screening to increase lung cancer screening rates amongst eligible participants. Imaging-based cancer screening is utilized with variable frequency. Breast cancer screening with mammography has been widely accepted and is commonly used among eligible women. Lung screening with computed tomography scans is poorly used, despite the potential to decrease deaths from lung cancer. There are many reasons lung screening isn't being used when compared to breast screening, such as smoking stigma and fear, along with a lack of awareness of lung screening. By conducting this trial, researchers want to assess the effectiveness of advocates and supporters of breast and lung screening, and to learn about the psychological barriers to cancer screening, identifying those that are unique to lung screening.
Interventions
- Behavioral: Health Education — Access electronic patient portal with educational material
- Other: Health Promotion and Education — Receive materials on breast/lung cancer screening
- Behavioral: Patient Navigation — Interact with a patient navigator
- Other: Survey Administration — Ancillary studies
Primary outcomes
- Increased rates of lung and breast cancer screening adherence (Up to 3 years)
Eligibility information
Study locations
- UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California 90095 United States
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.